Peter Rugg-Gunn, Ph.D., is a Group Leader within the Epigenetics Programme at the Babraham Institute and an Affiliate PI of the Cambridge Stem Cell Institute. His research interests centre on understanding how the epigenome is established during development and how this affects cell fate decisions in pluripotent stem cells and in embryos. His current work is focused on the mechanisms of epigenetic programming and reprogramming as human cells transition between pluripotent states. Peter trained with Professors Roger Pedersen (Cambridge) and Janet Rossant (Toronto) and then started his group at the Babraham Institute in 2011 funded by a Wellcome Trust RCDF. He was awarded tenure in 2017.